糖尿病合并2019冠状病毒病住院患者死亡率的入院前糖尿病特异性危险因素
该回顾性队列分析纳入2020年3月11日至5月7日纽约市一家大型学术医学中心1126例糖尿病合并COVID-19住院患者,评估HbA1c、门诊糖尿病治疗方案、人口学与临床特征与死亡率的关系。HbA1c水平与死亡率无关,而任何胰岛素治疗的门诊方案强烈预测死亡,肥胖与男性性别及年龄交互影响死亡率。
要点
- HbA1c水平在未调整和调整分析中均与死亡率无关。
- 门诊方案含任何胰岛素治疗强烈预测死亡率。
- 所有年龄组中,男性死亡率随BMI升高而高于女性。
核心结论
- 在该大型美国糖尿病合并COVID-19住院患者队列中,胰岛素治疗(可能作为糖尿病病程的替代指标)和肥胖而非长期血糖控制预测死亡率。
研究设计与样本
- 回顾性队列分析,纳入2020年3月11日至5月7日在纽约市一家大型学术医学中心住院的1126例确诊COVID-19的糖尿病患者,采用多变量建模评估HbA1c水平及门诊糖尿病治疗方案与死亡率的独立关联。
主要发现
- 队列平均年龄68岁,50%为男性,75%为黑人,平均BMI为30 kg/m2,98%为2型糖尿病,平均HbA1c为7.5%,33.1%死亡。
- HbA1c水平在未调整或调整分析中均与死亡率无关,但门诊方案含任何胰岛素治疗强烈预测死亡率。
- 年龄、性别和BMI存在交互作用,在所有年龄类别中,男性死亡率随BMI升高而高于女性。
关键数值与推荐
- 门诊方案含任何胰岛素治疗强烈预测死亡率。
- HbA1c水平在未调整或调整分析中均与死亡率无关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine whether HbA1c, outpatient diabetes treatment regimen, demographics, and clinical characteristics are associated with mortality in hospitalized patients with diabetes and coronavirus disease 2019 (COVID-19). RESEARCH DESIGN AND METHODS: This was a retrospective cohort analysis of patients with diabetes hospitalized with confirmed COVID-19 infection from 11 March to 7 May 2020 at a large academic medical center in New York City. Multivariate modeling was used to assess the independent association of HbA1c levels and outpatient diabetes treatment regimen with mortality, in addition to independent effects of demographic and clinical characteristics. RESULTS: We included 1,126 hospitalized patients with diabetes and COVID-19 for analysis, among whom mean age was 68 years, 50% were male, 75% were Black, mean BMI was 30 kg/m2, 98% had type 2 diabetes, mean HbA1c was 7.5%, and 33.1% died. HbA1c levels were not associated with mortality in unadjusted or adjusted analyses, but an outpatient regimen with any insulin treatment was strongly predictive. Additionally, age, sex, and BMI interacted such that in all age categories, mortality was higher with increasing BMI in males compared with females. CONCLUSIONS: In this large U.S. cohort of hospitalized patients with diabetes and COVID-19, insulin treatment, as a possible proxy for diabetes duration, and obesity rather than long-term glycemic control were predictive of mortality. Further investigation of underlying mechanisms of mortality and inpatient glycemic control is needed.
引用
- Agarwal S, Schechter C, Southern W, et al. Preadmission Diabetes-Specific Risk Factors for Mortality in Hospitalized Patients With Diabetes and Coronavirus Disease 2019. Diabetes Care. 2020. PMID: 32769128. doi:10.2337/dc20-1543
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。